At the 77th World Health Assembly in Geneva, Molbio Diagnostics’ Truenat platform was recognized as a transformative innovation in global healthcare. Praised by the Global Fund and health leaders, Truenat was highlighted for its role in decentralizing access to molecular diagnostics, particularly for tuberculosis. The portable, battery-operated, real-time PCR system enables rapid disease detection even in the most remote settings. The recognition reaffirms India’s leadership in health innovation and Molbio’s commitment to advancing equitable diagnostic access worldwide.
